Overexpressing CCT6A Contributes To Cancer Cell Growth By Affecting The G1-To-S Phase Transition And Predicts A Negative Prognosis In Hepatocellular Carcinoma.
Guofen ZengJialiang WangYanlin HuangYi-Fan LianDongmei ChenHuan WeiChaoshuang LinYuehua HuangPublished in: OncoTargets and therapy (2019)
CCT6A may contribute to HCC cell proliferation by accelerating the G1-to-S transition, as it maintains the expression of cyclin D. CCT6A could be considered an oncogene of HCC and could be used as a prognostic biomarker for HCC.